Clorox (NYSE:CLX) Shares Unloaded Rep. Jefferson Shreve

Representative Jefferson Shreve (R-Indiana) recently sold shares of The Clorox Company (NYSE:CLX). In a filing disclosed on May 08th, the Representative disclosed that they had sold between $15,001 and $50,000 in Clorox stock on April 11th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account.

Representative Jefferson Shreve also recently made the following trade(s):

  • Purchased $50,001 – $100,000 in shares of Chipotle Mexican Grill (NYSE:CMG) on 4/17/2025.
  • Purchased $50,001 – $100,000 in shares of Applied Materials (NASDAQ:AMAT) on 4/17/2025.
  • Purchased $15,001 – $50,000 in shares of Caterpillar (NYSE:CAT) on 4/17/2025.
  • Sold $15,001 – $50,000 in shares of Lululemon Athletica (NASDAQ:LULU) on 4/17/2025.
  • Purchased $15,001 – $50,000 in shares of Western Digital (NASDAQ:WDC) on 4/17/2025.
  • Sold $15,001 – $50,000 in shares of Zoetis (NYSE:ZTS) on 4/17/2025.
  • Purchased $15,001 – $50,000 in shares of Stryker (NYSE:SYK) on 4/17/2025.
  • Purchased $15,001 – $50,000 in shares of NextEra Energy (NYSE:NEE) on 4/17/2025.
  • Purchased $15,001 – $50,000 in shares of CSX (NASDAQ:CSX) on 4/17/2025.
  • Purchased $15,001 – $50,000 in shares of Ross Stores (NASDAQ:ROST) on 4/17/2025.

Clorox Price Performance

Shares of CLX stock opened at $134.79 on Friday. The business has a fifty day simple moving average of $142.37 and a 200 day simple moving average of $154.10. The company has a market cap of $16.60 billion, a P/E ratio of 36.83, a P/E/G ratio of 2.62 and a beta of 0.60. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The company’s revenue for the quarter was down 8.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.71 earnings per share. On average, sell-side analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd were paid a $1.22 dividend. The ex-dividend date of this dividend was Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.62%. Clorox’s payout ratio is 87.61%.

Insider Activity at Clorox

In related news, Director Pierre R. Breber purchased 4,000 shares of the firm’s stock in a transaction on Wednesday, May 7th. The stock was purchased at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the purchase, the director now owns 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.57% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on CLX shares. UBS Group dropped their price target on Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a research note on Thursday, April 17th. Morgan Stanley dropped their target price on Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a research report on Tuesday. JPMorgan Chase & Co. reduced their price target on Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a report on Tuesday. Barclays dropped their price objective on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating for the company in a report on Wednesday. Finally, DA Davidson reduced their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Clorox has a consensus rating of “Hold” and a consensus target price of $151.23.

Read Our Latest Stock Report on Clorox

Institutional Trading of Clorox

Institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of Clorox by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock valued at $2,293,135,000 after purchasing an additional 65,924 shares in the last quarter. Geode Capital Management LLC lifted its stake in Clorox by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company’s stock valued at $501,925,000 after buying an additional 69,969 shares during the period. Stifel Financial Corp boosted its holdings in shares of Clorox by 0.4% during the 4th quarter. Stifel Financial Corp now owns 2,344,408 shares of the company’s stock worth $380,761,000 after buying an additional 9,582 shares in the last quarter. Norges Bank acquired a new stake in shares of Clorox during the 4th quarter worth approximately $259,041,000. Finally, Northern Trust Corp increased its stake in shares of Clorox by 18.2% in the 4th quarter. Northern Trust Corp now owns 1,494,265 shares of the company’s stock valued at $242,684,000 after acquiring an additional 230,173 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana’s 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana’s 6th Congressional District. He declared candidacy for the 2026 election.

Email [email protected] to notify us of updates to this biography.
Jefferson Shreve earned a bachelor’s degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve’s career experience includes working as a real estate executive.

Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.